Stockscreener 앱 받기
3.37
1.75%
-0.06
시장 영업 전:
3.41
0.04
+1.19%
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Niagen Bioscience Q1 2026 slides: e-commerce surges 14% amid transition - Investing.com
Earnings call transcript: Niagen Bioscience Q1 2026 sees growth in e-commerce - Investing.com
Assessing Niagen Bioscience (NAGE) Valuation As It Renames Its NAD+ Research Program - Yahoo Finance
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science - Business Wire
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference - Stock Titan
Is Niagen Bioscience’s (NAGE) NAD+ Research Push Quietly Redefining Its Competitive Moat? - simplywall.st
Niagen Bioscience (NAGE) Rebrands Research Program - GuruFocus
Niagen Bioscience renames research program By Investing.com - Investing.com Nigeria
Niagen Bioscience renames research program - Investing.com
Q4 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Q1 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Q2 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Q3 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
NAGE Stock Price, Quote & Chart | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
NAGE Technical Analysis | Trend, Signals & Chart Patterns | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD+ Dietary Supplement Claims - The Manila Times
National Advertising Review Board Recommends Niagen Modify - GlobeNewswire
NAGE News | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience Earnings Call Highlights Growth Push - TipRanks
How The Niagen Bioscience (NAGE) Story Is Shifting As Price Targets Edge Lower - Yahoo Finance
Is Niagen Bioscience’s (NAGE) Telehealth Niagen Plus Launch a Turning Point in Its Direct-Access Strategy? - simplywall.st
Niagen Bioscience stock price target lowered to $11 by H.C. Wainwright - Investing.com Australia
HC Wainwright Lowers Niagen Bioscience (NASDAQ:NAGE) Price Target to $11.00 - MarketBeat
Assessing Niagen Bioscience (NAGE) Valuation After Earnings Strength And New NAD Plus Delivery Initiatives - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results - Post Register
Will Niagen Bioscience’s (NAGE) Telehealth NAD+ Push Redefine Its Core Therapeutic Focus? - Yahoo Finance
Biotech Innovator Niagen Uncovers Breakthrough NAD+ Booster, Reports Strong Q1 Results - Streetwise Reports
Niagen Bioscience Announces Participation in Upcoming Investor Conferences - PharmiWeb.com
Niagen Bioscience Announces Participation in Upcoming May 2026 Investor Conferences - BioSpace
Niagen Bioscience Q1 2026 slides: e-commerce surges 14% amid transition By Investing.com - Investing.com South Africa
Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED) - Benzinga
Niagen Bioscience reaffirms 10%-15% 2026 growth outlook while increasing marketing spend expectations - MSN
Niagen Bioscience Inc Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Niagen Bioscience Q1 2026 sees growth in e-commerce By Investing.com - Investing.com South Africa
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Niagen (NAGE) Q1 2026 Earnings Call Transcript - AOL.com
2.60%
0.94%
자본화:
|
볼륨(24시간):